Open access
Aug 2026
Integrative single-cell eQTL and multi-omics analyses reveal AIM1 and ANXA1 as immune-related hub genes and potential therapeutic targets in head and neck cancer
An integrative single-cell eQTL-driven multi-omics framework to identify immune cell-specific causal genes and prioritize drug-repurposing candidates for HNC supports AIM1 and ANXA1 as promising biomarkers and therapeutic entry points for precision drug development.
Zhangwei Xue, Guo-Hang Shen, Gongbiao Lin et al.
· Frontiers in Oncology · 0 citations